The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Neutrophil Priming: Pathophysiological Consequences and Underlying Mechanisms
Abstract
1. Neutrophil priming by agents such as tumour necrosis factor-α, granulocyte/macrophage colony-stimulating factor and lipopolysaccharide causes a dramatic increase in the response of these cells to an activating agent; this process has been shown to be critical for neutrophil-mediated tissue injury both in vitro and in vivo. 2. The principle consequence of priming, aside from a direct effect on cell polarization, deformability and integrin/selectin expression, is to permit secretagogue-induced superoxide anion generation, degranulation and lipid mediator (e.g. leukotriene B4 and arachidonic acid) release. It is now recognized that most priming agents also serve an additional function of delaying apoptosis and hence increasing the functional longevity of these cells at the inflamed site. 3. The potential mechanisms underlying priming are discussed; current data suggest a dissociation between priming and changes in receptor number and/or affinity, G-protein expression, phospholipase C and phospholipase A2 activation and changes in intracellular Ca2+ concentration. However, more recent studies support a key role for protein tyrosine phosphorylation and enhanced phospholipase D and phosphoinositide 3-kinase activity in neutrophil priming. 4. Recent work has also revealed the potential for neutrophils to spontaneously and fully ‘de-prime’ after an initial challenge with platelet-activating factor. This ability of neutrophils to undergo a complete cycle of priming—de-priming (and re-priming) reveals a previously unrecognized flexibility in the control of neutrophil behaviour at an inflamed site.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Babior, B. M., Kipnes, R. S., & Curnutte, J. T. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107236 · Cited by 2,931
Leukocyte-endothelial adhesion molecules
Carlos, T., & Harlan, J. (1994) · Blood · doi:10.1182/blood.v84.7.2068.2068 · Cited by 2,701
cPLA2 is phosphorylated and activated by MAP kinase
Lin, L.-L., Wartmann, M., Lin, A. Y., Knopf, J. L., Seth, A., & Davis, R. J. (1993) · Cell · doi:10.1016/0092-8674(93)90666-e · Cited by 1,849
Arcaro, A., & Wymann, M. P. (1993) · Biochemical Journal · doi:10.1042/bj2960297 · Cited by 1,140
Haslett, C., Guthrie, L. A., Kopaniak, M. M., Johnston, R. B., & Henson, P. M. (1985) · PubMed Central · Cited by 779
Guthrie, L. A., McPhail, L. C., Henson, P. M., & Johnston, R. B. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.6.1656 · Cited by 616
Smedly, L. A., Tonnesen, M. G., Sandhaus, R. A., Haslett, C., Guthrie, L. A., Johnston, R. B., Henson, P. M., & Worthen, G. S. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112426 · Cited by 567
The Gβγ Sensitivity of a PI3K Is Dependent upon a Tightly Associated Adaptor, p101
Stephens, L. R., Eguinoa, A., Erdjument-Bromage, H., Lui, M., Cooke, F., Coadwell, J., Smrcka, A. S., Thelen, M., Cadwallader, K., Tempst, P., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80187-7 · Cited by 557
PDGF stimulates an increase in GTP–Rac via activation of phosphoinositide 3-kinase
Hawkins, P. T., Eguinoa, A., Qiu, R.-G., Stokoe, D., Cooke, F. T., Walters, R., Wennström, S., Claesson-Welsh, L., Evans, T., Symons, M., et al. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00080-7 · Cited by 542
Subunits βγ of heterotrimeric G protein activate β2 isoform of phospholipase C
Katz, A., Wu, D., & Simon, M. I. (1992) · Nature · doi:10.1038/360686a0 · Cited by 513
Cited by
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
Barnes, P. J., Shapiro, S. D., & Pauwels, R. A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00040703 · Cited by 1,439
Neutrophil kinetics in health and disease
Summers, C., Rankin, S. M., Condliffe, A. M., Singh, N., Peters, A. M., & Chilvers, E. R. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.05.006 · Cited by 1,242
Self-citationMediators of Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.2 · Cited by 710
Neutrophils: Between Host Defence, Immune Modulation, and Tissue Injury
Kruger, P., Saffarzadeh, M., Weber, A. N. R., Rieber, N., Radsak, M., von Bernuth, H., Benarafa, C., Roos, D., Skokowa, J., & Hartl, D. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004651 · Cited by 657
Systemic inflammation after trauma
Lenz, A., Franklin, G. A., & Cheadle, W. G. (2007) · Injury · doi:10.1016/j.injury.2007.10.003 · Cited by 600
Neutrophils: New insights and open questions
Ley, K., Hoffman, H. M., Kubes, P., Cassatella, M. A., Zychlinsky, A., Hedrick, C. C., & Catz, S. D. (2018) · Science Immunology · doi:10.1126/sciimmunol.aat4579 · Cited by 534
Priming of the neutrophil respiratory burst: role in host defense and inflammation
El‐Benna, J., Hurtado‐Nedelec, M., Marzaioli, V., Marie, J., Gougerot‐Pocidalo, M., & Dang, P. M. (2016) · Immunological Reviews · doi:10.1111/imr.12447 · Cited by 478
Cassuto, J., Sinclair, R., & Bonderovic, M. (2006) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2006.00936.x · Cited by 464
Pillay, J., Tak, T., Kamp, V. M., & Koenderman, L. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1286-4 · Cited by 375
The Role of Sodium Channels in Chronic Inflammatory and Neuropathic Pain
Amir, R., Argoff, C. E., Bennett, G. J., Cummins, T. R., Durieux, M. E., Gerner, P., Gold, M. S., Porreca, F., & Strichartz, G. R. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2006.01.444 · Cited by 362
Mookerjee, R. P., Stadlbauer, V., Lidder, S., Wright, G. A. K., Hodges, S. J., Davies, N. A., & Jalan, R. (2007) · Hepatology · doi:10.1002/hep.21737 · Cited by 332
Kurt-Jones, E. A., Mandell, L., Whitney, C., Padgett, A., Gosselin, K., Newburger, P. E., & Finberg, R. W. (2002) · Blood · doi:10.1182/blood.v100.5.1860.h81702001860_1860_1868 · Cited by 318
GM-CSF Autoantibodies and Neutrophil Dysfunction in Pulmonary Alveolar Proteinosis
Uchida, K., Beck, D. C., Yamamoto, T., Berclaz, P.-Y., Abe, S., Staudt, M. K., Carey, B. C., Filippi, M.-D., Wert, S. E., Denson, L. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062505 · Cited by 317
SCFAs Induce Mouse Neutrophil Chemotaxis through the GPR43 Receptor
Vinolo, M. A. R., Ferguson, G. J., Kulkarni, S., Damoulakis, G., Anderson, K., Bohlooly-Y, M., Stephens, L., Hawkins, P. T., & Curi, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021205 · Cited by 292
Stadlbauer, V., Mookerjee, R. P., Hodges, S., Wright, G. A. K., Davies, N. A., & Jalan, R. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.015 · Cited by 288
Hwang, J. H., Lyes, M., Sladewski, K., Enany, S., McEachern, E., Mathew, D. P., Das, S., Moshensky, A., Bapat, S., Pride, D. T., et al. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1378-3 · Cited by 280
NADPH oxidase activation in neutrophils: Role of the phosphorylation of its subunits
Belambri, S. A., Rolas, L., Raad, H., Hurtado‐Nedelec, M., Dang, P. M., & El‐Benna, J. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12951 · Cited by 265
McLeish, K. R., Uriarte, S. M., Tandon, S., Creed, T. M., Le, J., & Ward, R. A. (2013) · Journal of Innate Immunity · doi:10.1159/000345992 · Cited by 32
Novel Assay To Characterize Neutrophil Responses to Oral Biofilms
Oveisi, M., Shifman, H., Fine, N., Sun, C., Glogauer, N., Senadheera, D., & Glogauer, M. (2019) · Infection and Immunity · doi:10.1128/iai.00790-18 · Cited by 30
Paloschi, M. V., Boeno, C. N., Lopes, J. A., Rego, C. M. A., Silva, M. D. S., Santana, H. M., Serrath, S. N., Ikenohuchi, Y. J., Farias, B. J. C., Felipin, K. P., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120962 · Cited by 26
Metadata
- Authors
- Condliffe, A. M., Kitchen, E., & Chilvers, E. R.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 1998-05-01
- Volume
- 94
- Issue
- 5
- Pages
- 461-471
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W1631483568
- Cited by
- 362
- References
- 59
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.